Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Gilead obtains worldwide rights for novel HIV integrase inhibitors from Boehringer Ingelheim

Oct. 6, 2011

Dynavax Technologies and AstraZeneca accelerate development of candidate asthma therapy

Oct. 6, 2011

Evotec confirms second collaboration with UCB

Oct. 6, 2011

Celgene and Agios Pharmaceuticals expand cancer metabolism partnership

Oct. 6, 2011

Merck Serono and Ono Pharmaceutical collaborate on MS drug and cancer vaccine

Oct. 5, 2011

Intellect Neurosciences and ViroPharma enter licensing agreement for OX-1

Oct. 5, 2011

MedImmune in-licenses tremelimumab from Pfizer

Oct. 4, 2011

Children's Oncology Group and Apeiron to collaborate on phase II study in neuroblastoma

Oct. 3, 2011

NanoCarrier and Kowa to enter worldwide agreement for NC-6300

Sep. 30, 2011

JDRF and iCo Therapeutics partner to support phase II iCo-007 study

Sep. 30, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...